Nordicus Partners Corporation (NORD)
NASDAQ: NORD · Real-Time Price · USD
4.912
-0.178 (-3.50%)
At close: Oct 30, 2026, 4:00 PM EDT
3.650
-1.262 (-25.69%)
After-hours: Oct 30, 2026, 7:49 PM EDT
Company Description
Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States.
It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023.
Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.
Nordicus Partners Corporation
| Country | United States |
| Founded | 1993 |
| Industry | Consulting Services |
| Sector | Industrials |
| CEO | Henrik Rouf |
Contact Details
Address: 280 South Beverly Dr, Suite 505 Beverly Hills, California 90212 United States | |
| Phone | 310 666 0750 |
| Website | nordicuspartners.com |
Stock Details
| Ticker Symbol | NORD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001011060 |
| CUSIP Number | 28265K304 |
| ISIN Number | US28265K3041 |
Key Executives
| Name | Position |
|---|---|
| Henrik Rouf | Chief Executive Officer and President |
| Bennett Jay Yankowitz | Chief Financial Officer and Director |